StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for BLGO yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $0.13 | $0.13 | -1.54% | 0.1M |
| 05-18 | $0.13 | $0.12 | -10.98% | 0.7M |
| 05-19 | $0.11 | $0.11 | -3.25% | 1.3M |
| 05-20 | $0.12 | $0.11 | -3.72% | 0.5M |
| 05-21 | $0.11 | $0.14 | +22.81% | 1.3M |
BIOLARGO INC
Fundamentals not available for BLGO yet.
We pull from FMP, Finnhub, and Polygon — common gaps are very recent IPOs that haven't filed their first 10-Q, pink-sheet OTC tickers, and foreign filers without US-listed depth. The Financials tab reads SEC EDGAR directly and may still have data here.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.11M | $7.76M | $7.15M | $6.05M |
Operating Income | $-3.20M | $-14.86M | $-10.84M | $-3.66M |
Net Income | $-3.40M | $-15.19M | $-11.05M | $-3.80M |
EPS (Diluted) | $-0.01 | $-0.04 | $-0.03 | $-0.01 |
Total Assets | $8.56M | $8.31M | $9.13M | $12.50M |
Total Liabilities | $8.75M | $6.79M | $5.92M | $6.44M |
Cash & Equivalents | $4.12M | $3.88M | $4.55M | $3.47M |
Free Cash Flow OCF − CapEx | $-2.95M | $-8.34M | $-6.74M | $-3.95M |
Shares Outstanding | 318.70M | 306.95M | 304.51M | 302.24M |